5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-N-[2-[1-[(5R)-5-hydroxyhexyl]-7-methyl-2,6-dioxopurin-3-yl]ethyl]pentanamide

C24H37N7O5S — CID 11627998

IUPAC5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-N-[2-[1-[(5R)-5-hydroxyhexyl]-7-methyl-2,6-dioxopurin-3-yl]ethyl]pentanamide
SMILESC[C@@H](O)CCCCn1c(=O)c2c(ncn2C)n(CCNC(=O)CCCC[C@@H]2SC[C@@H]3NC(=O)N[C@@H]32)c1=O
InChIInChI=1S/C24H37N7O5S/c1-15(32)7-5-6-11-31-22(34)20-21(26-14-29(20)2)30(24(31)36)12-10-25-18(33)9-4-3-8-17-19-16(13-37-17)27-23(35)28-19/h14-17,19,32H,3-13H2,1-2H3,(H,25,33)(H2,27,28,35)/t15-,16+,17+,19+/m1/s1
InChIKeyAOVCOHVBTWDCBZ-DFEOGRTESA-N
MW535.67 g/mol
LogP0.29
Rot. Bonds13

About 5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-N-[2-[1-[(5R)-5-hydroxyhexyl]-7-methyl-2,6-dioxopurin-3-yl]ethyl]pentanamide

5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-N-[2-[1-[(5R)-5-hydroxyhexyl]-7-methyl-2,6-dioxopurin-3-yl]ethyl]pentanamide (PubChem CID 11627998) has the molecular formula C24H37N7O5S and a molecular weight of 535.67 g/mol. Its IUPAC name is 5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-N-[2-[1-[(5R)-5-hydroxyhexyl]-7-methyl-2,6-dioxopurin-3-yl]ethyl]pentanamide.

Molecular Properties

Compound Name5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-N-[2-[1-[(5R)-5-hydroxyhexyl]-7-methyl-2,6-dioxopurin-3-yl]ethyl]pentanamide
PubChem CID11627998
Molecular FormulaC24H37N7O5S
Molecular Weight535.67 g/mol
Exact Mass535.26
IUPAC Name5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-N-[2-[1-[(5R)-5-hydroxyhexyl]-7-methyl-2,6-dioxopurin-3-yl]ethyl]pentanamide
SMILESC[C@@H](O)CCCCn1c(=O)c2c(ncn2C)n(CCNC(=O)CCCC[C@@H]2SC[C@@H]3NC(=O)N[C@@H]32)c1=O
InChIInChI=1S/C24H37N7O5S/c1-15(32)7-5-6-11-31-22(34)20-21(26-14-29(20)2)30(24(31)36)12-10-25-18(33)9-4-3-8-17-19-16(13-37-17)27-23(35)28-19/h14-17,19,32H,3-13H2,1-2H3,(H,25,33)(H2,27,28,35)/t15-,16+,17+,19+/m1/s1
InChIKeyAOVCOHVBTWDCBZ-DFEOGRTESA-N
XLogP0.29
TPSA152.28 Ų
H-Bond Donors4
H-Bond Acceptors10
Rotatable Bonds13
Heavy Atoms37
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500535.67
LogP ≤ 50.29
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1010

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'biotin_analogue', 'substructure': 'N/A'}

Analyze 5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-N-[2-[1-[(5R)-5-hydroxyhexyl]-7-methyl-2,6-dioxopurin-3-yl]ethyl]pentanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-N-[2-[1-[(5R)-5-hydroxyhexyl]-7-methyl-2,6-dioxopurin-3-yl]ethyl]pentanamide?
The IUPAC name of 5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-N-[2-[1-[(5R)-5-hydroxyhexyl]-7-methyl-2,6-dioxopurin-3-yl]ethyl]pentanamide (CID 11627998) is 5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-N-[2-[1-[(5R)-5-hydroxyhexyl]-7-methyl-2,6-dioxopurin-3-yl]ethyl]pentanamide.
What is the SMILES notation for 5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-N-[2-[1-[(5R)-5-hydroxyhexyl]-7-methyl-2,6-dioxopurin-3-yl]ethyl]pentanamide?
The canonical SMILES for 5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-N-[2-[1-[(5R)-5-hydroxyhexyl]-7-methyl-2,6-dioxopurin-3-yl]ethyl]pentanamide is C[C@@H](O)CCCCn1c(=O)c2c(ncn2C)n(CCNC(=O)CCCC[C@@H]2SC[C@@H]3NC(=O)N[C@@H]32)c1=O.
What is the InChIKey of 5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-N-[2-[1-[(5R)-5-hydroxyhexyl]-7-methyl-2,6-dioxopurin-3-yl]ethyl]pentanamide?
The InChIKey is AOVCOHVBTWDCBZ-DFEOGRTESA-N. The full InChI is InChI=1S/C24H37N7O5S/c1-15(32)7-5-6-11-31-22(34)20-21(26-14-29(20)2)30(24(31)36)12-10-25-18(33)9-4-3-8-17-19-16(13-37-17)27-23(35)28-19/h14-17,19,32H,3-13H2,1-2H3,(H,25,33)(H2,27,28,35)/t15-,16+,17+,19+/m1/s1.
What are the key properties of 5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-N-[2-[1-[(5R)-5-hydroxyhexyl]-7-methyl-2,6-dioxopurin-3-yl]ethyl]pentanamide?
5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-N-[2-[1-[(5R)-5-hydroxyhexyl]-7-methyl-2,6-dioxopurin-3-yl]ethyl]pentanamide has a molecular weight of 535.67 g/mol, XLogP of 0.29, 13 rotatable bonds, 4 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for 5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-N-[2-[1-[(5R)-5-hydroxyhexyl]-7-methyl-2,6-dioxopurin-3-yl]ethyl]pentanamide is sourced from PubChem (CID 11627998), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).